GHRP-6 Acetate

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that acts as a growth hormone secretagogue. Studied for its activation of the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor. As one of the earliest and most thoroughly investigated GHRPs, it serves as a reference compound in endocrine peptide research.

GHRP-6 has the ability to promote growth hormone secretion independently of growth hormone–releasing hormone (GHRH). Its well-defined receptor binding profile and consistent signalling responses make it useful for modelling pituitary stimulation by peptides and exploring ghrelin-related endocrine pathways.

Research specifics:
Non-clinical studies in several research areas, including:

• Growth Hormone Secretion Modelling: Investigating patterns of pulsatile GH release through direct stimulation of the ghrelin receptor.
• Ghrelin Receptor Binding Studies: Assessing receptor affinity, activation thresholds, and the resulting downstream signalling pathways.
• Endocrine Axis Research: Modelling peptide-based signalling within the hypothalamic–pituitary regulatory system.
• Metabolic Signalling Pathways: Examining downstream effects linked to nutrient sensing and energy balance regulation.
• Comparative Secretagogue Analysis: Used alongside compounds such as GHRP-2, Hexarelin, and Ipamorelin to evaluate differences in potency, duration of action, and receptor selectivity.